Hypertensive atherosclerotic cardiovascular disease
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest that hypertension is a significant and modifiable risk factor for atherosclerotic cardiovascular disease, and managing it through antihypertensive therapy and addressing multiple risk factors can reduce cardiovascular events.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta19 papers analyzed
Hypertensive Atherosclerotic Cardiovascular Disease: An Overview
Introduction to Hypertensive Atherosclerotic Cardiovascular Disease
Hypertensive atherosclerotic cardiovascular disease (ASCVD) is a significant health concern, characterized by the interplay between high blood pressure (hypertension) and the buildup of atherosclerotic plaques in the arteries. This condition leads to severe cardiovascular complications, including coronary heart disease, stroke, and peripheral arterial disease.
Hypertension and Its Role in Atherosclerosis
Mechanical Stress and Vascular Damage
Hypertension exerts mechanical stress on the cardiovascular system, particularly on the heart and blood vessels. This stress leads to fibromuscular thickening of the arterial walls and luminal narrowing, which accelerates the development of atherosclerosis. The physical strain from elevated blood pressure aggravates atherosclerotic processes, especially in the coronary and cerebral vessels, increasing the risk of myocardial infarction and stroke.
Humoral Factors and Vasoactive Hormones
While mechanical stress is a primary factor, humoral factors and vasoactive hormones such as angiotensin and catecholamines also contribute to hypertensive cardiovascular disease. These elements, although secondary, play a role in the pathogenesis of the disease by influencing vascular tone and promoting inflammatory responses.
Risk Stratification and Assessment
ASCVD Risk in Hypertensive Patients
Risk stratification is crucial for managing hypertensive patients. Studies have shown that a significant proportion of hypertensive adults are at high risk for ASCVD. Factors such as diabetes, dyslipidemia, and obesity significantly elevate this risk. For instance, diabetic and dyslipidemic patients are substantially more likely to be at high risk for ASCVD.
Impact of New Hypertension Guidelines
The 2017 American College of Cardiology/American Heart Association guidelines redefined hypertension, lowering the threshold to 130/80 mm Hg. This redefinition has significant implications for patients with systemic lupus erythematosus, as those with sustained blood pressure in the 130-139/80-89 mm Hg range have a higher incidence of atherosclerotic vascular events compared to normotensive individuals.
Co-Risk Factors and Their Interactions
Diabetes and Hypertension
Hypertension is prevalent among diabetic patients and is a strong risk factor for ASCVD. Effective antihypertensive therapy can reduce ASCVD events, heart failure, and microvascular complications in diabetic individuals. Addressing multiple risk factors simultaneously yields substantial benefits in reducing cardiovascular morbidity and mortality.
Smoking and Dyslipidemia
Smoking and dyslipidemia are significant co-risk factors that exacerbate the effects of hypertension on atherosclerosis. These factors contribute to endothelial dysfunction, lipid deposition, and inflammatory responses, further promoting atherogenesis.
Pathophysiological Mechanisms
Vascular Smooth Muscle Cells (VSMCs)
VSMCs play a critical role in the progression of both hypertension and atherosclerosis. Angiotensin II, a major effector protein in hypertension, and hypercholesterolemia synergistically affect VSMCs, promoting vascular pathology. Understanding these interactions is key to developing targeted therapies for hypertensive atherosclerotic cardiovascular disease.
Circadian Rhythms and Chronotherapy
Circadian rhythms influence various pathophysiological processes in atherosclerosis and hypertension. Disruptions in circadian rhythms, such as those caused by shift work or sleep apnea, can exacerbate these conditions. Chronotherapy, which aligns treatment with the body's biological clock, may offer improved management of hypertensive atherosclerotic disease.
Conclusion
Hypertensive atherosclerotic cardiovascular disease is a complex condition driven by the interplay of high blood pressure and atherosclerosis. Effective management requires comprehensive risk assessment and addressing multiple co-risk factors. Advances in understanding the pathophysiological mechanisms and the role of circadian rhythms offer promising avenues for improving patient outcomes.
Sources and full results
Most relevant research papers on this topic
